These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Zohar J; Insel TR Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259 [TBL] [Abstract][Full Text] [Related]
4. Effects of imipramine on depression and obsessive-compulsive symptoms. Foa EB; Steketee G; Kozak MJ; Dugger D Psychiatry Res; 1987 Jun; 21(2):123-36. PubMed ID: 3615688 [TBL] [Abstract][Full Text] [Related]
5. The sleep of patients with obsessive-compulsive disorder. Insel TR; Gillin JC; Moore A; Mendelson WB; Loewenstein RJ; Murphy DL Arch Gen Psychiatry; 1982 Dec; 39(12):1372-7. PubMed ID: 7149896 [TBL] [Abstract][Full Text] [Related]
6. Urinary free cortisol levels in obsessive-compulsive disorder. Gehris TL; Kathol RG; Black DW; Noyes R Psychiatry Res; 1990 May; 32(2):151-8. PubMed ID: 2367600 [TBL] [Abstract][Full Text] [Related]
7. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II. Mavissakalian M; Turner SM; Michelson L; Jacob R Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761 [TBL] [Abstract][Full Text] [Related]
8. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder. Insel TR; Kalin NH; Guttmacher LB; Cohen RM; Murphy DL Psychiatry Res; 1982 Apr; 6(2):153-60. PubMed ID: 6953457 [TBL] [Abstract][Full Text] [Related]
9. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior. Kim SW; Dysken MW; Pandey GN; Davis JM Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222 [TBL] [Abstract][Full Text] [Related]
10. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. Vallejo J; Olivares J; Marcos T; Bulbena A; Menchón JM Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616 [TBL] [Abstract][Full Text] [Related]
11. HPA axis disturbance in obsessive-compulsive disorder. Coryell WH; Black DW; Kelly MW; Noyes R Psychiatry Res; 1989 Dec; 30(3):243-51. PubMed ID: 2694203 [TBL] [Abstract][Full Text] [Related]
16. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131 [TBL] [Abstract][Full Text] [Related]
17. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls. Black DW; Kelly M; Myers C; Noyes R Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266 [TBL] [Abstract][Full Text] [Related]